386873009: Lisinopril (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\...

\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin-converting enzyme inhibitor\Lisinopril (substance)

\Hydrolase inhibitor\Peptide hydrolase inhibitor\Angiotensin-converting enzyme inhibitor\Lisinopril (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin-converting enzyme inhibitor\Lisinopril (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Dipeptide (substance)\Lisinopril (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Dipeptide (substance)\Lisinopril (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lisinopril (substance)	Is a	Angiotensin-converting enzyme inhibitor	true	Inferred relationship	Some
Lisinopril (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Angiotensin-converting enzyme inhibitor (disposition)	true	Inferred relationship	Some
Lisinopril (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Lisinopril (substance)	Is a	Dipeptide (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing lisinopril (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril adverse reaction	Causative agent (attribute)	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril allergy	Causative agent (attribute)	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril+diuretic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Lisinopril 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some
Product containing hydrochlorothiazide and lisinopril (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Non-allergic hypersensitivity to lisinopril	Causative agent (attribute)	False	Lisinopril (substance)	Inferred relationship	Some
Non-allergic hypersensitivity to lisinopril	Causative agent (attribute)	True	Lisinopril (substance)	Inferred relationship	Some	1
Non-allergic hypersensitivity to lisinopril	Causative agent (attribute)	False	Lisinopril (substance)	Inferred relationship	Some	2
Lisinopril 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 2.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Lisinopril (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Lisinopril (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Lisinopril (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Lisinopril (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Lisinopril (substance)	Inferred relationship	Some	2
Lisinopril 2.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 30 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Lisinopril (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Hydrochlorothiazide and lisinopril only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing only lisinopril (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Hydrochlorothiazide and lisinopril only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	1
Lisinopril dihydrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Lisinopril (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	1
Product containing only amlodipine and lisinopril (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine- and lisinopril-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine- and lisinopril-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine and lisinopril only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Lisinopril (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Lisinopril (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and lisinopril 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Lisinopril (substance)	Inferred relationship	Some	2
Lisinopril anhydrous (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Lisinopril (substance)	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461051018	Lisinopril (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480987013	Lisinopril	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49771000195112	lisinopril	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
821001000172113	lisinopril	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
63951000195110	Lisinopril	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module